Table 2.

Mean lipid profile by gender and glucose tolerance in the study population (n=1840)

Parameters	Men					Women
NGTc	IFG2	DMe	pa	pb	NGTc	IFGd	DMe	pa	pb
Total cholesterol	185.15±38.96	186.92±38.45	201.08±42.59	0.014	0.640c,d; 0.003*c-e; 0.024d,e	186.01±36.29	200.44±39.83	217.97±51.78	<0.001	<0.001*c,d; <0.001*c–e; 0.008*d-e
Triglycerides	128.27±73.60	149.22±98.20	162.41±94.95	<0.001	0.005c,d; 0.002*c–e; 0.239d-e	98.03±53.44	125.03±74.80	173.22±110.15	<0.001	<0.001*c,d; <0.001*c–e; <0.001*d,e
HDL cholesterol	46.16±12.46	47.22±10.72	46.32±12.27	0.653	0.358c,d; 0.988c–e; 0.596d-e	53.70±15.46	53.54±17.78	50.42±14.31	0.369	0.924c,d; 0.158c–e; 0.252d,e
LDL cholesterol	121.44±31.36	121.89±26.17	130.00±43.01	0.297	0.915c,d; 0.119c–e; 0.220d-e	118.35±29.68	131.93±36.29	138.36±40.51	<0.001	0.006*c,d; 0.002*c–e; 0.406d-e
ApoA	131.47±21.64	128.97±23.51	135.32±21.82	0.504	0.507c,d; 0.377c–e; 0.243d-e	139.72±22.92	136.13±19.69	146.88±20.36	0.258	0.362c,d; 0.205c–e; 0.243d,e
ApoB	97.64±25.02	98.05±20.15	105.21±21.12	0.291	0.922c,d; 0.117c–e; 0.233d,e	87.15±22.53	99.89±20.78	121.17±30.85	<0.001	0.002*c,d; <0.001*c–e; 0.002*d,e
Non-HDL cholesterol	139.33±37.54	140.07±38.14	154.83±39.10	0.013	0.838c,d; 0.003c–e; 0.015d-e	132.91±34.78	147.21±38.75	167.55±49.17	<0.001	<0.001*c,d; <0.001*c–e; 0.001*d,e
Total/HDL cholesterol ratio	4.61±4.64	4.15±1.23	6.08±9.19	0.040	0.316c,d; 0.027*c–e; 0.012*d–e	4.19±4.60	4.26±2.82	5.05±3.97	0.413	0.871c,d; 0.184c–e; 0.307d,e
LDL/apoB ratio	1.27±0.19	1.26±0.19	1.20±0.32	0.283	0.862c,d; 0.112c–e; 0.247d–e	1.37±0.15	1.37±0.24	1.23±0.15	0.007	0.855c,d; 0.002*c–e; 0.005*d,e
ApoB/A ratio	0.75±0.19	0.79±0.25	0.78±0.16	0.366	0.232c,d; 0.373c–e; 0.909d,e	0.63±0.18	0.74±0.18	0.84±0.26	<0.001	0.001*c,d; <0.001*c–e; 0.079d,e

Notes: ^ap-value of ANOVA; ^bp-value of LSD. *Significant (p<0.05). ^1–2: NGT (normal glucose tolerance) vs IFG (impaired fasting glycemia); ^c–eNGT vs DM (diabetes mellitus); ^d,eIFG vs DM.